Elman retina group

Baltimore, Maryland 21237

0 studies enrolling now · 12 studies all time

What they study most

Age Related Macular Degeneration, Age-related Macular Degeneration, Cataract, Choroidal Neovascularization, Diabetic Macular Edema, Diabetic Macular Edema(DME), Exudative Macular Degeneration, Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Proliferative Diabetic Retinopathy

Studies at this site

• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
• Evaluation of Tonabersat for DME — Running, not enrolling
• The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME) — Completed
• The Study to YD312 Tablet in Patients With Diabetic Macular Edema — Status unconfirmed
• A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy — Completed
• An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy — Stopped early
• Retrospective Review of Proliferative Diabetic Retinopathy Patients — Status unconfirmed
• Pilot Study of X-82 in Patients With Wet AMD — Completed
• Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy — Stopped early
• Age-Related Eye Disease Study 2 (AREDS2) — Completed
• Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration — Completed
• Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema — Stopped early